rs1429977258

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_006015.6(ARID1A):​c.193C>G​(p.Pro65Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000324 in 1,232,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P65L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000018 ( 0 hom. )

Consequence

ARID1A
NM_006015.6 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.14

Publications

4 publications found
Variant links:
Genes affected
ARID1A (HGNC:11110): (AT-rich interaction domain 1A) This gene encodes a member of the SWI/SNF family, whose members have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. It possesses at least two conserved domains that could be important for its function. First, it has a DNA-binding domain that can specifically bind an AT-rich DNA sequence known to be recognized by a SNF/SWI complex at the beta-globin locus. Second, the C-terminus of the protein can stimulate glucocorticoid receptor-dependent transcriptional activation. It is thought that the protein encoded by this gene confers specificity to the SNF/SWI complex and may recruit the complex to its targets through either protein-DNA or protein-protein interactions. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ARID1A Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • intellectual disability, autosomal dominant 14
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15775216).
BP6
Variant 1-26696596-C-G is Benign according to our data. Variant chr1-26696596-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445779.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1ANM_006015.6 linkc.193C>G p.Pro65Ala missense_variant Exon 1 of 20 ENST00000324856.13 NP_006006.3
ARID1ANM_139135.4 linkc.193C>G p.Pro65Ala missense_variant Exon 1 of 20 NP_624361.1
LOC124900417XM_047439473.1 linkc.-191G>C upstream_gene_variant XP_047295429.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1AENST00000324856.13 linkc.193C>G p.Pro65Ala missense_variant Exon 1 of 20 1 NM_006015.6 ENSP00000320485.7

Frequencies

GnomAD3 genomes
AF:
0.0000133
AC:
2
AN:
150758
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000296
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000185
AC:
2
AN:
1082162
Hom.:
0
Cov.:
35
AF XY:
0.00000390
AC XY:
2
AN XY:
512888
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22612
American (AMR)
AF:
0.00
AC:
0
AN:
8146
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14056
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25986
South Asian (SAS)
AF:
0.00
AC:
0
AN:
21020
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21756
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2894
European-Non Finnish (NFE)
AF:
0.00000217
AC:
2
AN:
922336
Other (OTH)
AF:
0.00
AC:
0
AN:
43356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000133
AC:
2
AN:
150758
Hom.:
0
Cov.:
32
AF XY:
0.0000136
AC XY:
1
AN XY:
73612
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41076
American (AMR)
AF:
0.00
AC:
0
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5044
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10338
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
308
European-Non Finnish (NFE)
AF:
0.0000296
AC:
2
AN:
67570
Other (OTH)
AF:
0.00
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Sep 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 07, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Uncertain:1
Apr 07, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.193C>G (p.P65A) alteration is located in exon 1 (coding exon 1) of the ARID1A gene. This alteration results from a C to G substitution at nucleotide position 193, causing the proline (P) at amino acid position 65 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
23
DANN
Benign
0.91
DEOGEN2
Benign
0.073
T;.
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.078
N
LIST_S2
Benign
0.63
T;T
M_CAP
Pathogenic
0.84
D
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
1.1
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
0.39
N;N
REVEL
Benign
0.043
Sift
Pathogenic
0.0
D;D
Sift4G
Benign
1.0
T;T
Vest4
0.27
ClinPred
0.29
T
GERP RS
2.2
PromoterAI
-0.068
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
3.9
Varity_R
0.13
gMVP
0.091
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1429977258; hg19: chr1-27023087; API